Report cover image

Global Pyrimethamine Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 196 Pages
SKU # APRC20280376

Description

Summary

According to APO Research, the global Pyrimethamine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Pyrimethamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Pyrimethamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Pyrimethamine market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Pyrimethamine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Pyrimethamine market include Taj Accura Pharmaceuticals, PRN Pharmacal, NCBO BioPortal and Evaluate, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pyrimethamine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pyrimethamine, also provides the sales of main regions and countries. Of the upcoming market potential for Pyrimethamine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pyrimethamine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pyrimethamine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pyrimethamine sales, projected growth trends, production technology, application and end-user industry.

Pyrimethamine Segment by Company

Taj Accura Pharmaceuticals
PRN Pharmacal
NCBO BioPortal
Evaluate
Pyrimethamine Segment by Type

Capsules Pyrimethamine
Tablets Pyrimethamine
Injectables Pyrimethamine
Pyrimethamine Segment by Application

Clinic
Hospital
Laboratory
Others
Pyrimethamine Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Pyrimethamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pyrimethamine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pyrimethamine significant trends, drivers, influence factors in global and regions.
6. To analyze Pyrimethamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pyrimethamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pyrimethamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pyrimethamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pyrimethamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pyrimethamine industry.
Chapter 3: Detailed analysis of Pyrimethamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pyrimethamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pyrimethamine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pyrimethamine Sales Value (2020-2031)
1.2.2 Global Pyrimethamine Sales Volume (2020-2031)
1.2.3 Global Pyrimethamine Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Pyrimethamine Market Dynamics
2.1 Pyrimethamine Industry Trends
2.2 Pyrimethamine Industry Drivers
2.3 Pyrimethamine Industry Opportunities and Challenges
2.4 Pyrimethamine Industry Restraints
3 Pyrimethamine Market by Company
3.1 Global Pyrimethamine Company Revenue Ranking in 2024
3.2 Global Pyrimethamine Revenue by Company (2020-2025)
3.3 Global Pyrimethamine Sales Volume by Company (2020-2025)
3.4 Global Pyrimethamine Average Price by Company (2020-2025)
3.5 Global Pyrimethamine Company Ranking (2023-2025)
3.6 Global Pyrimethamine Company Manufacturing Base and Headquarters
3.7 Global Pyrimethamine Company Product Type and Application
3.8 Global Pyrimethamine Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Pyrimethamine Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Pyrimethamine Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Pyrimethamine Market by Type
4.1 Pyrimethamine Type Introduction
4.1.1 Capsules Pyrimethamine
4.1.2 Tablets Pyrimethamine
4.1.3 Injectables Pyrimethamine
4.2 Global Pyrimethamine Sales Volume by Type
4.2.1 Global Pyrimethamine Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pyrimethamine Sales Volume by Type (2020-2031)
4.2.3 Global Pyrimethamine Sales Volume Share by Type (2020-2031)
4.3 Global Pyrimethamine Sales Value by Type
4.3.1 Global Pyrimethamine Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pyrimethamine Sales Value by Type (2020-2031)
4.3.3 Global Pyrimethamine Sales Value Share by Type (2020-2031)
5 Pyrimethamine Market by Application
5.1 Pyrimethamine Application Introduction
5.1.1 Clinic
5.1.2 Hospital
5.1.3 Laboratory
5.1.4 Others
5.2 Global Pyrimethamine Sales Volume by Application
5.2.1 Global Pyrimethamine Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pyrimethamine Sales Volume by Application (2020-2031)
5.2.3 Global Pyrimethamine Sales Volume Share by Application (2020-2031)
5.3 Global Pyrimethamine Sales Value by Application
5.3.1 Global Pyrimethamine Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pyrimethamine Sales Value by Application (2020-2031)
5.3.3 Global Pyrimethamine Sales Value Share by Application (2020-2031)
6 Pyrimethamine Regional Sales and Value Analysis
6.1 Global Pyrimethamine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pyrimethamine Sales by Region (2020-2031)
6.2.1 Global Pyrimethamine Sales by Region: 2020-2025
6.2.2 Global Pyrimethamine Sales by Region (2026-2031)
6.3 Global Pyrimethamine Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Pyrimethamine Sales Value by Region (2020-2031)
6.4.1 Global Pyrimethamine Sales Value by Region: 2020-2025
6.4.2 Global Pyrimethamine Sales Value by Region (2026-2031)
6.5 Global Pyrimethamine Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Pyrimethamine Sales Value (2020-2031)
6.6.2 North America Pyrimethamine Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Pyrimethamine Sales Value (2020-2031)
6.7.2 Europe Pyrimethamine Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pyrimethamine Sales Value (2020-2031)
6.8.2 Asia-Pacific Pyrimethamine Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Pyrimethamine Sales Value (2020-2031)
6.9.2 South America Pyrimethamine Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pyrimethamine Sales Value (2020-2031)
6.10.2 Middle East & Africa Pyrimethamine Sales Value Share by Country, 2024 VS 2031
7 Pyrimethamine Country-level Sales and Value Analysis
7.1 Global Pyrimethamine Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Pyrimethamine Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Pyrimethamine Sales by Country (2020-2031)
7.3.1 Global Pyrimethamine Sales by Country (2020-2025)
7.3.2 Global Pyrimethamine Sales by Country (2026-2031)
7.4 Global Pyrimethamine Sales Value by Country (2020-2031)
7.4.1 Global Pyrimethamine Sales Value by Country (2020-2025)
7.4.2 Global Pyrimethamine Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Pyrimethamine Sales Value Growth Rate (2020-2031)
7.5.2 USA Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Pyrimethamine Sales Value Growth Rate (2020-2031)
7.6.2 Canada Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Pyrimethamine Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Pyrimethamine Sales Value Growth Rate (2020-2031)
7.8.2 Germany Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Pyrimethamine Sales Value Growth Rate (2020-2031)
7.9.2 France Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.9.3 France Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Pyrimethamine Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Pyrimethamine Sales Value Growth Rate (2020-2031)
7.11.2 Italy Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Pyrimethamine Sales Value Growth Rate (2020-2031)
7.12.2 Spain Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Pyrimethamine Sales Value Growth Rate (2020-2031)
7.13.2 Russia Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Pyrimethamine Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Pyrimethamine Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Pyrimethamine Sales Value Growth Rate (2020-2031)
7.16.2 China Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.16.3 China Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Pyrimethamine Sales Value Growth Rate (2020-2031)
7.17.2 Japan Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Pyrimethamine Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Pyrimethamine Sales Value Growth Rate (2020-2031)
7.19.2 India Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.19.3 India Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Pyrimethamine Sales Value Growth Rate (2020-2031)
7.20.2 Australia Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Pyrimethamine Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Pyrimethamine Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Pyrimethamine Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Pyrimethamine Sales Value Growth Rate (2020-2031)
7.24.2 Chile Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Pyrimethamine Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Pyrimethamine Sales Value Growth Rate (2020-2031)
7.26.2 Peru Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Pyrimethamine Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Pyrimethamine Sales Value Growth Rate (2020-2031)
7.28.2 Israel Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Pyrimethamine Sales Value Growth Rate (2020-2031)
7.29.2 UAE Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Pyrimethamine Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Pyrimethamine Sales Value Growth Rate (2020-2031)
7.31.2 Iran Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Pyrimethamine Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Pyrimethamine Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Pyrimethamine Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Pyrimethamine Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Taj Accura Pharmaceuticals
8.1.1 Taj Accura Pharmaceuticals Comapny Information
8.1.2 Taj Accura Pharmaceuticals Business Overview
8.1.3 Taj Accura Pharmaceuticals Pyrimethamine Sales, Value and Gross Margin (2020-2025)
8.1.4 Taj Accura Pharmaceuticals Pyrimethamine Product Portfolio
8.1.5 Taj Accura Pharmaceuticals Recent Developments
8.2 PRN Pharmacal
8.2.1 PRN Pharmacal Comapny Information
8.2.2 PRN Pharmacal Business Overview
8.2.3 PRN Pharmacal Pyrimethamine Sales, Value and Gross Margin (2020-2025)
8.2.4 PRN Pharmacal Pyrimethamine Product Portfolio
8.2.5 PRN Pharmacal Recent Developments
8.3 NCBO BioPortal
8.3.1 NCBO BioPortal Comapny Information
8.3.2 NCBO BioPortal Business Overview
8.3.3 NCBO BioPortal Pyrimethamine Sales, Value and Gross Margin (2020-2025)
8.3.4 NCBO BioPortal Pyrimethamine Product Portfolio
8.3.5 NCBO BioPortal Recent Developments
8.4 Evaluate
8.4.1 Evaluate Comapny Information
8.4.2 Evaluate Business Overview
8.4.3 Evaluate Pyrimethamine Sales, Value and Gross Margin (2020-2025)
8.4.4 Evaluate Pyrimethamine Product Portfolio
8.4.5 Evaluate Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pyrimethamine Value Chain Analysis
9.1.1 Pyrimethamine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pyrimethamine Sales Mode & Process
9.2 Pyrimethamine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pyrimethamine Distributors
9.2.3 Pyrimethamine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.